The myocardial ischemia evaluated by real-time contrast echocardiography may predict the response to cardiac

Yongle Chen1, Leilei Cheng1, Haohua Yao1

  • 1Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai Institute of Medical Imaging, Shanghai, PR China.

Plos One
|December 4, 2014
PubMed

Insights

Real-time myocardial contrast echocardiography (RT-MCE) can predict cardiac resynchronization therapy (CRT) response in ischemic cardiomyopathy. Myocardial blood flow (MBF) measured by RT-MCE is a superior predictor compared to standard strain metrics.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Preclinical Research

Background:

  • Evidence-based criteria for cardiac resynchronization therapy (CRT) in ischemic cardiomyopathy are limited.
  • Preclinical models are crucial for evaluating novel diagnostic tools.

Purpose of the Study:

  • To assess the predictive value of real-time myocardial contrast echocardiography (RT-MCE) for CRT response.
  • To compare RT-MCE with standard strain imaging in a canine model of ischemic cardiomyopathy.

Main Methods:

  • Ischemic cardiomyopathy induced in 20 beagles by ligating the first diagonal branch.
  • Dogs randomized to CRT (bi-ventricular pacing) or control groups.
  • RT-MCE and 2D speckle tracking imaging performed at baseline and 4 weeks post-CRT.

Main Results:

  • CRT improved circumferential strain (Cir12SD), radial strain (R12SD), and myocardial blood flow (MBF).
  • Pre-CRT MBF was significantly higher in CRT responders versus non-responders.
  • RT-MCE showed 83.3% sensitivity and 100% specificity for predicting CRT response using MBF >24.9 dB/s.

Conclusions:

  • Myocardial perfusion assessed by RT-MCE is superior to standard LV synchrony metrics for selecting CRT candidates.
  • CRT improves myocardial perfusion and cardiac synchrony in ischemic cardiomyopathy.
  • RT-MCE is a valuable tool for predicting CRT efficacy.